🎄🌟 🎉 Wishing our readers a Merry Christmas and a Happy New Year filled with new possibilities! 🎄🌟 🎉
Eisai joins REMAP-CAP on innovative trial to combat COVID-19
Japan | News | 0 Comment | 06 Jul, 2020
US based Global Coalition for Adaptive Research and Japanese firm Eisai Co., Ltd., in collaboration with UPMC (Universit...Read more
Japan begins research on vitals measurement headset
Japan | News | 0 Comment | 03 Jul, 2020
Kyocera Corporation and Tokyo Medical and Dental University (TMDU) announced a joint research project to develop a wirel...Read more
Daiichi Sankyo in discussion with AZ for COVID-19 vaccine supply
Japan | News | 0 Comment | 02 Jul, 2020
Japan based Daiichi Sankyo Company, Limited has announced its agreement to proceed with discussions with AstraZeneca for...Read more
Japan reveals breakthrough research in cancer
Japan | News | 0 Comment | 01 Jul, 2020
Researchers in Japan claim that they have replicated cancer cells from diseased bladder tissue in dogs, minimizing the u...Read more
Japan repurposes hypertension vaccine for COVID-19 treatment
Japan | News | 0 Comment | 29 Jun, 2020
The Osaka-based Japanese biotech AnGes Inc. expects its potential COVID-19 vaccine to be ready as early as the first hal...Read more
Japan develops saliva test to detect COVID-19 in 30-min
Japan | News | 0 Comment | 26 Jun, 2020
Nihon University and Tokyo Medical University are developing a novel RT-PCR method for detection of SARS-CoV2 virus. Unl...Read more
Thermo Fisher, Daiichi Sankyo to co-develop CDx for NSCLC
Japan | News | 0 Comment | 30 Jun, 2020
Thermo Fisher Scientific and Daiichi Sankyo have expanded their partnership by signing a new agreement to co-develo...Read more
Cardiovascular disease (CVD) impact on Asia-Pacific markets
Japan | Analysis | 2 Comment | 23 Jun, 2020
HONG KONG Prevalence CVD, including heart attack and stroke, is the third leading cause of death in Hong Kong (aft...Read more
EIU launches APAC Economist Intelligence Unit report for heart ailments
Japan | News | 0 Comment | 23 Jun, 2020
The Cost of Inaction: Secondary Prevention of Cardiovascular Disease in Asia-Pacific Rehabilitation ...Read more
Daiichi Sankyo to develop mRNA vaccine against COVID-19
Japan | News | 0 Comment | 23 Jun, 2020
Daiichi Sankyo Company, Limited has announced its decision to develop a genetic (mRNA) vaccine for the novel corona viru...Read more
Japan develops breakthrough treatment for osteoarthritis
Japan | News | 0 Comment | 24 Jun, 2020
A break through feat of growing pluripotency expressing cells from osteoarthritis (OA) affected cartilage tissue of knee...Read more
Santen, Orbis to develop training tools for eye care
Japan | News | 0 Comment | 25 Jun, 2020
Japanese firm Santen Pharmaceutical Co., Ltd. and US based Orbis International have announced a partnership to develop a...Read more
Joimax develops partnership with Japan Medicalnext
Japan | News | 0 Comment | 22 Jun, 2020
Joimax, the German based market leader in technologies and training methods for full-endoscopic and minimally invasive s...Read more
Japan studies genetic differences of COVID-19 and SARS viruses
Japan | News | 0 Comment | 19 Jun, 2020
Researchers at the University of Tokyo in Japan have identified specific portions of the genetic codes of the COVID-19 a...Read more
Takeda partners with Neurocrine Biosciences to focus on psychiatric disorders
Japan | News | 0 Comment | 18 Jun, 2020
US based Neurocrine Biosciences, Inc. and Japanese firm Takeda Pharmaceutical Company Limited have announced a...Read more
Astellas develops science based exercise programs
Japan | News | 0 Comment | 16 Jun, 2020
Astellas Pharma Inc. has developed science-based exercise programs in cooperation with the City of Yokohama, Kanag...Read more
Takeda to divest select APAC assets to Celltrion for $278M
Japan | News | 0 Comment | 15 Jun, 2020
Japanese firm Takeda Pharmaceutical Company Limited has announced that it has entered into an agreement to divest a...Read more
AbbVie, Genmab enter $4B cancer immunotherapy partnership
Japan | News | 0 Comment | 11 Jun, 2020
US-based AbbVie and Genmab announced on 10 June 2020 that they had formed the partnership that will focus on b...Read more